EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Analysis of the efficacy of fosfomycin trometamol in preventing biofilm bacterial infection in double-J stents among diabetic patients and the factors associated with infection

Jun Bing Ye, Ke Zeng, Xiao Bin Li, Jian Yang, SuChuan Zhang, Qian Chen

International Urology and Nephrology · 2026

DOI: 10.1007/s11255-026-05080-w ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Urology and Nephrology, 2026. Verfasst von Jun Bing Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, First People's Hospital of Zigong City, Zigong, 643000, Sichuan, China. Hauptthemen laut MEDLINE: Biofilms, Fosfomycin, Anti-Bacterial Agents, Stents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the General Project of the Scientific Research Program of the Zigong Municipal Health Commission, the High-Quality Development Project of the First People's Hospital of Zigong City, the Scientific Research Project of the Zigong Medical Academy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the efficacy of fosfomycin trometamol powder (FMT) in preventing biofilm-associated bacterial infections on double-J stents in diabetic patients; to characterize the species distribution and antimicrobial susceptibility patterns of biofilm-forming bacteria isolated from these devices; and to identify clinical and microbiological risk factors associated with such infections-thereby informing evidence-based strategies for infection prevention in this high-risk population. METHODS: A total of 100 adult diabetic patients who underwent double-J stent placement at our tertiary care center between June 2024 and June 2025 were prospectively enrolled and randomized in a 1:1 ratio to either an experimental group or a control group (n = 50 per group). Patients in the experimental group received a single oral dose of 3 g FMT on the day before stent insertion and on postoperative days 7 and 15; those in the control group received a single oral dose of 0.5 g levofloxacin (LFX) tablets on the day before stent insertion and on postoperative days 1 and 2. At the time of stent removal, stent surface specimens were collected for quantitative biofilm-forming bacterial culture, species identification, and antimicrobial susceptibility testing. Baseline clinical characteristics, stent-related symptoms, and infection outcomes were systematically recorded. Statistical analysis was conducted using SPSS version 26.0, with two-sided p 110 μmol/L, and glycated hemoglobin (HbA1c) > 6% as independent risk factors for biofilm-associated bacterial infection (p < 0.05). CONCLUSION: When administered with equivalent dosing frequency (three doses total), FMT was associated with a significantly lower detection rate of biofilm-forming bacteria in double-J stent specimens compared with LFX among diabetic patients. These findings support the preferential use of FMT over LFX for targeted prophylaxis in high-risk diabetic populations and underscore the importance of integrating antimicrobial stewardship-particularly agent selection aligned with local resistance patterns-with proactive management of modifiable risk factors to optimize infection prevention and clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsFosfomycinAnti-Bacterial AgentsStentsProsthesis-Related InfectionsDiabetes ComplicationsHumansFemaleMaleMiddle AgedAgedProspective StudiesRisk FactorsDiabetes Mellitus

Stichwörter der Autor:innen

Biofilm bacteriaDiabetesDouble-J stentInfectionRisk factors

Substanzen

FosfomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Urology, First People's Hospital of Zigong City, Zigong, 643000, Sichuan, China.
  • Department of Laboratory Medicine, First People's Hospital of Zigong City, Zigong, 643000, Sichuan, China.
  • Department of Nephrology, First People's Hospital of Zigong City, Zigong, 643000, Sichuan, China. 13890889739@163.com.

Förderung

  • the General Project of the Scientific Research Program of the Zigong Municipal Health Commission
  • the High-Quality Development Project of the First People's Hospital of Zigong City
  • the Scientific Research Project of the Zigong Medical Academy

Zitieren

APA

Ye, J. B., Zeng, K., Li, X. B., Yang, J., Zhang, S., & Chen, Q. (2026). Analysis of the efficacy of fosfomycin trometamol in preventing biofilm bacterial infection in double-J stents among diabetic patients and the factors associated with infection. International Urology and Nephrology. https://doi.org/10.1007/s11255-026-05080-w

Vancouver

Ye JB, Zeng K, Li XB, Yang J, Zhang S, Chen Q. Analysis of the efficacy of fosfomycin trometamol in preventing biofilm bacterial infection in double-J stents among diabetic patients and the factors associated with infection. International Urology and Nephrology. 2026. doi:10.1007/s11255-026-05080-w

BibTeX
@article{Ye2026,
  author = {Ye, Jun Bing and Zeng, Ke and Li, Xiao Bin and Yang, Jian and Zhang, SuChuan and Chen, Qian},
  title = {Analysis of the efficacy of fosfomycin trometamol in preventing biofilm bacterial infection in double-J stents among diabetic patients and the factors associated with infection},
  journal = {International Urology and Nephrology},
  year = {2026},
  doi = {10.1007/s11255-026-05080-w}
}
Kostenlos starten →